The International AIDS Vaccine Initiative (IAVI) has issued a report that provides a detailed summary of work for the period 1 January to 31 December 2003.
Some of the highlights of the European Programme are:
2003 saw a further increase in the involvement of European groups in IAVI’s work. In addition to the clinical trials underway in Kenya, Uganda, South Africa and the UK, trials began in Switzerland and Belgium in 2003, and applications were submitted for trials in Germany and The Netherlands in early 2004.
The European Union awarded IAVI funding for the first time, with an announcement that it would provide 3 million Euro in matching funds for IAVI’s vaccine preparedness activities in East Africa for 2004-2006.
IAVI received renewed support from the government of The Netherlands, Ireland, Norway and Denmark.
Ireland has shown a leadership role in expanding commitment to vaccines and microbiocides during their EU Presidency and is actively cooperating with countries holding the EU Presidency over the next few years; The Netherlands, Luxembourg and the UK.
To read the "IAVI annual progress report" click here.
